Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

DSpace Repository

Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant

Author: Tolaney, Sara M.; Toi, Masakazu; Neven, Patrick; Sohn, Joohyuk; Grischke, Eva-Maria; Llombart-Cussac, Antonio; Soliman, Hatem; Wang, Hong; Wijayawardana, Sameera; Jansen, Valerie M.; Litchfield, Lacey M.; Sledge, George W., Jr.
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Clinical Cancer Research (2022), Bd. 28, H. 8, S. 1500-1506
Verlagsangabe: Amer Assoc Cancer Research
Language: English
Full text: http://dx.doi.org/10.1158/1078-0432.CCR-21-3276
ISSN: 1078-0432
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)